Supplementary Methods from Metformin Sensitizes EGFR-TKI–Resistant Human Lung Cancer Cells &lt;i&gt;In Vitro&lt;/i&gt; and &lt;i&gt;In Vivo&lt;/i&gt; through Inhibition of IL-6 Signaling and EMT Reversal